logo
episode-header-image
Sep 2022
25m 18s

Disparities in Multiple Myeloma: Exposin...

MEDSCAPE
About this episode

Drs Joseph Mikhael and Brandon Blue reveal the impact of disparities in multiple myeloma and pave a path forward to culturally competent care.

Relevant disclosures can be found with the episode show notes on Medscape (https://www.medscape.com/viewarticle/964342). The topics and discussions are planned, produced, and reviewed independently of advertisers. This podcast is intended only for US healthcare professionals.

Resources

Multiple Myeloma Awareness and African American Disparities https://www.cancer.gov/about-nci/organization/crchd/blog/2017/multiple-myeloma-disparities

Multiple Myeloma https://emedicine.medscape.com/article/204369-overview

International Myeloma Foundation https://www.myeloma.org/

International Myeloma Foundation Launches "M-Power Charlotte" to Improve Outcomes in Multiple Myeloma, a Cancer That Disproportionately Affects African Americans https://www.myeloma.org/international-myeloma-foundation-launches-m-power-charlotte-improve-outcomes-multiple-myeloma

The Tuskegee Timeline https://www.cdc.gov/tuskegee/timeline.htm

Up next
Aug 2022
Multiple Myeloma Therapies: A Glimpse Into the Future
Drs Joseph Mikhael and Nina Shah discuss the exciting future in multiple myeloma in which bispecifics, CELMoDs, modakafusp, and easily delivered CAR T-cell therapy all may play a role. Relevant disclosures can be found with the episode show notes on Medscape (https://www.medscape ... Show More
24m 27s
Jul 2022
Triple-Class Refractory Multiple Myeloma: What Is the Approach? What Are the Challenges?
Joseph Mikhael, MD, and Saad Usmani, MD, discuss options in managing triple-class refractory multiple myeloma including selinexor, belantamab mafodotin, and CAR T-cell therapy. Relevant disclosures can be found with the episode show notes on Medscape (https://www.medscape.com/vie ... Show More
21m 34s
Jun 2022
Addressing Comorbidities in Multiple Myeloma: Treating People, Not the Disease
Joseph Mikhael, MD, and Ashley Rosko, MD, discuss the role of comorbidities in multiple myeloma and stress the importance of shifting away from the sole use of age-based treatment decisions. Relevant disclosures can be found with the episode show notes on Medscape.com (https://ww ... Show More
20m 18s
Recommended Episodes
Feb 2025
A medical mythbuster's mission to improve health care | Joel Bervell
Joel Bervell was one of the only Black students in his medical school program. After noticing how misconceptions about race were embedded in health care, he turned to social media to raise awareness about the harmful impact of biases in medicine. He unpacks the long history of ra ... Show More
28m 27s
Apr 29
Tackling bias in health
Bias in the way medical research is carried out means that new medicines for diseases such as cancer – as well as the tools used to diagnose patients with some conditions – are disproportionally tested on people of European heritage. This can lead to those not represented in the ... Show More
23m 18s
Apr 2022
Structural racism and AML survival, promoter competition and hemoglobin switching, and CAR T-cell therapy and high-risk cytogenetics in ALL
In this week’s episode we’ll first cover a research article demonstrating the striking contribution of neighborhood disadvantage to racial and ethnic disparities in survival in patients with acute myeloid leukemia. The second research article provides a model for understanding ho ... Show More
17m 55s
May 2024
EP 133: Insights into pharmacogenomics and increasing diversity in genomics research with Dr. Emma Magavern
Join us as we welcome Dr. Emma Magavern to The Genetics Podcast! In addition to being a medical doctor with an English Literature degree, Dr. Magovern is a Clinical Research Fellow at the Centre of Clinical Pharmacology and Precision Medicine at Queen Mary, Barts, and the London ... Show More
39m 17s
Apr 28
#346 - Scaling biotech and improving global health: lessons from an extraordinary career in medicine | Susan Desmond-Hellmann, M.D., M.P.H.
View the Show Notes Page for This Episode Become a Member to Receive Exclusive Content Sign Up to Receive Peter’s Weekly Newsletter Susan Desmond-Hellmann is a physician and scientist whose remarkable career has spanned clinical medicine, oncology, biotech innovation, and global ... Show More
2h 5m
Apr 2020
Dr. Anantha Shekhar and Translating Research into Treatments
On this episode of the Healthcare Triage podcast, Aaron is talking to Dr. Anantha Shekhar, founding director of the Indiana Clinical and Translational Sciences Institute (CTSI) and leader of the IU Precision Health Initiative. You’ll learn about the importance of translational re ... Show More
25m 59s
Oct 2024
A medical mythbuster's mission to improve health care | Joel Bervell
Joel Bervell was one of the only Black students in his medical school program. After noticing how misconceptions about race were embedded in health care, he turned to social media to raise awareness about the harmful impact of biases in medicine. He unpacks the long history of ra ... Show More
20m 13s
Dec 2024
2024 State of Lung Cancer: The Hopes and Hurdles of Precision Oncology with Dr. Jacob Sands
For a probing discussion detailing the American Lung Association’s recent 2024 “State of Lung Cancer” report, we are joined by esteemed thoracic medical oncologist Dr. Jacob Sands of Dana-Farber Cancer Institute and Harvard Medical School. Offering insight into actionable targete ... Show More
33m 9s
Sep 2024
Episode 354: Antiracism in Medicine – Episode 25 – Live from SGIM 2024: Best of Antiracism Research at the Society of General Internal Medicine’s 2024 Annual Meeting
  https://clinicalproblemsolving.com/wp-content/uploads/2024/09/CPSolvers-SGIM-2024-Episode-FINAL-91924-12.19PM.mp3CPSolvers: Anti-Racism in Medicine SeriesEpisode 25 – Live from SGIM 2024: Best of Antiracism Research at the Society of General Internal Medicine’s 2024 Annual Meet ... Show More
57m 38s
Dec 2024
Primary resistance to BCMA-targeted bispecifics in multiple myeloma, emapalumab therapy in hemophagocytic lymphohistiocytosis, and chemotherapy-induced pyroptosis as a mechanism of thrombus formation
In this week's episode, we’ll learn more about mechanisms of primary resistance to BCMA-targeted bispecific T-cell engagers in relapsed/refractory multiple myeloma, the effects of emapalumab therapy on outcomes in patients with pediatric hemophagocytic lymphohistiocytosis who rec ... Show More
20m 5s